FGFR2

About

Location: 10q26.13

Mappings

HGNC: HGNC:3689

Ensembl: NM_000141.5

NCBI: ENSG00000066468

Refseq: 2263

Biomarkers

FGFR2 is involved in the following curated biomarkers.

Name Biomarker type Propositions Statements
FGFR2::v Rearrangement 4 5
FGFR2 rearrangements Rearrangement 3 3
FGFR2::BICC1 Rearrangement 1 1
FGFR2::CASP7 Rearrangement 1 1

Therapeutic response

Precision oncology relationships for therapeutic response involving this gene.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) FGFR2::v Intrahepatic Cholangiocarcinoma Futibatinib
Sensitivity (+) FGFR2::v Cholangiocarcinoma Infigratinib
Sensitivity (+) FGFR2::v Cholangiocarcinoma Pemigatinib
Sensitivity (+) FGFR2 rearrangements Cholangiocarcinoma Pemigatinib
Sensitivity (+) FGFR2::v Intrahepatic Cholangiocarcinoma Futibatinib
Sensitivity (+) FGFR2 rearrangements Intrahepatic Cholangiocarcinoma Futibatinib
Sensitivity (+) FGFR2::v Intrahepatic Cholangiocarcinoma Elacestrant
Sensitivity (+) FGFR2 rearrangements Intrahepatic Cholangiocarcinoma Elacestrant
Sensitivity (+) FGFR2::BICC1 Bladder Urothelial Carcinoma Erdafitinib
Sensitivity (+) FGFR2::CASP7 Bladder Urothelial Carcinoma Erdafitinib